For potential new treatment combining BioArctic’s BrainTransporter technology with an undisclosed target in neurodegeneration ...

Asimov, a synthetic biology company, entered a cell line development partnership with Ottimo Pharma, a biopharmaceutical ...

Cold Chain Technologies (CCT) is intensifying its expansion in the Asia Pacific (APAC) region through targeted investments ...

Asymchem, a global contract development and manufacturing organization (CDMO), has expanded its flow chemistry capabilities ...

The European Commission (EC) has approved Bio-Thera Solutions Inc.’s BAT2206 (ustekinumab), a biosimilar referencing Stelara.

Ken McFarlane of CluePoints shares insight on better, smarter ways to detect risk, streamline data review, and automate ...

Bio-Rad Laboratories has introduced a new range of StarBright Dyes, providing greater choice and flexibility for spectral ...

With over two decades of experience, Katcheves previously served at Teva, Bristol Myers Squibb, and Lonza Group.

AbbVie has agreed to acquire Gilgamesh Pharmaceuticals Inc.’s lead investigational candidate, currently in clinical ...

The European Commission has granted marketing authorization for Yeytuo (lenacapavir)—Gilead Sciences Inc.’s twice-yearly ...

Genentech, a member of the Roche Group, has broken ground on its newest U.S. manufacturing site in Holly Springs, North ...

Adva Biotechnology Ltd. and Autolomous Ltd. have joined forces to co-lead an early adopter initiative focused on digitizing, ...